Lantern Pharma(LTRN) - 2022 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Lantern Pharma Inc. (Exact name of registrant as specified in its charter) | Delaware | 001-39318 | 46-3973463 | | --- | --- | --- | | (State or Other Jurisdiction | (Commission File Number) | (IRS Employer | | of Incorporation) | | Identification No.) | | 1920 McKinney Avenue, 7th Floor Dallas, Texas | | 75201 | (Address of Principal Executive ...